← All stocks

REGENXBIO Inc.

RGNX Net selling
CIK 0001590877 #2797 in the set updated 17 Sep 2026
Bought (120 mo)
$949.38K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$100.66M
$1.08M on a plan · $67.00M straight out of an exercise
Sold at will
$32.57M
135 of 340 sales
Net
−$99.71M
−$31.62M against sales at will

By person

20 insiders · 361 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Mills Kenneth T.
Director
$25.72M (109)
−$25.72M
495,925
0.7513%
$4.64M
+255.7%
Vasista Vittal
Chief Financial Officer
$19.04M (83)
−$19.04M
246,534
0.3735%
$2.31M
+113.6%
Simpson Curran
Chief Executive Officer
$17.42M (30) scheduled
−$17.42M
338,053
0.5121%
$3.16M
HAYDEN DONALD J JR
Director
$9.34M (19) scheduled
−$9.34M
0
0.0000%
$0.00
−100.0%
Yoo Stephen
Chief Medical Officer
$8.72M (31) scheduled
−$8.72M
0
0.0000%
$0.00
Christmas Patrick J.
Chief Strategy & Legal Officer
$6.41M (34) scheduled
−$6.41M
205,968
0.3120%
$1.93M
Fox Allan M.
Director
$6.09M (4)
−$6.09M
5,926,520
8.98%
$55.45M
−2.2%
BESHAR LUKE M
Director
$4.18M (7) scheduled
−$4.18M
0
0.0000%
$0.00
PAKOLA STEVE
Chief Medical Officer
$1.73M (9) scheduled
−$1.73M
205,541
0.3114%
$1.92M
Danos Olivier
Chief Scientific Officer
$1.38M (6) scheduled
−$1.38M
226,348
0.3429%
$2.12M
Ciongoli Gregory Austin
Director
$949.38K (2)
+$949.38K
118,035
0.1788%
$1.10M
KARABELAS ARGERIS N
Director
$631.28K (8) scheduled
−$631.28K
28,861
0.0437%
$270.02K
Chan Mitchell
Chief Financial Officer
122,815
0.1860%
$1.15M
Malzahn Craig
Chief Technology Officer
81,960
0.1242%
$766.82K
+360.0%
Zachary Jennifer
Director
31,871
0.0483%
$298.19K
MIGAUSKY GEORGE V
Director
28,861
0.0437%
$270.02K
Tasse Daniel
Director
28,861
0.0437%
$270.02K
STUMP DAVID C
Director
28,861
0.0437%
$270.02K
Glucksmann Alexandra
Director
28,861
0.0437%
$270.02K
Bennett Jean
Director
28,861
0.0437%
$270.02K
Insider
Date
Role
Action
Shares
Price
Amount
Ciongoli Gregory Austin
27 Aug 2026
Director
Buy
53,407
$9.36
$499.68K
Ciongoli Gregory Austin
26 Aug 2026
Director
Buy
49,196
$9.14
$449.71K
Showing 250 of 361 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 356
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 197
Sales at will 135
Transactions with no price 0
Shares from compensation/vesting 5,738,322
Sales filed before the plan box existed 134
History held since 12 Dec 2016